Biomolecules,
Journal Year:
2021,
Volume and Issue:
11(9), P. 1367 - 1367
Published: Sept. 16, 2021
Until
recently,
astrocytes
were
thought
to
be
a
part
of
simple
“brain
glue”
providing
only
supporting
role
for
neurons.
However,
the
discoveries
last
two
decades
have
proven
dynamic
partners
participating
in
brain
metabolism
and
actively
influencing
communication
between
The
means
astrocyte-neuron
are
diverse,
although
regulated
exocytosis
has
received
most
attention
but
also
caused
debate.
Similar
eukaryotic
cells,
complex
range
vesicular
organelles
which
can
undergo
as
well
intricate
molecular
mechanisms
that
regulate
this
process.
In
review,
we
focus
on
components
needed
occur
summarise
knowledge
about
experimental
evidence
showing
its
presence
astrocytes.
Frontiers in Neuroscience,
Journal Year:
2023,
Volume and Issue:
17
Published: Feb. 23, 2023
Traumatic
brain
injury
(TBI)
results
when
external
physical
forces
impact
the
head
with
sufficient
intensity
to
cause
damage
brain.
TBI
can
be
mild,
moderate,
or
severe
and
may
have
long-term
consequences
including
visual
difficulties,
cognitive
deficits,
headache,
pain,
sleep
disturbances,
post-traumatic
epilepsy.
Disruption
of
normal
functioning
leads
a
cascade
effects
molecular
anatomical
changes,
persistent
neuronal
hyperexcitation,
neuroinflammation,
loss.
Destructive
processes
that
occur
at
cellular
level
lead
inflammation,
oxidative
stress,
calcium
dysregulation,
apoptosis.
Vascular
damage,
ischemia
loss
blood
barrier
integrity
contribute
destruction
tissue.
This
review
focuses
on
incited
during
frequently
life-altering
lasting
this
vision,
cognition,
balance,
sleep.
The
wide
range
complaints
associated
are
addressed
repair
where
there
is
potential
for
intervention
preservation
highlighted.
Biomedicines,
Journal Year:
2022,
Volume and Issue:
10(5), P. 1206 - 1206
Published: May 23, 2022
Astrocytes
are
essential
for
normal
brain
development
and
functioning.
They
respond
to
injury
disease
through
a
process
referred
as
reactive
astrogliosis,
where
the
reactivity
is
highly
heterogenous
context-dependent.
Reactive
astrocytes
active
contributors
pathology
can
exert
beneficial,
detrimental,
or
mixed
effects
following
insults.
Transforming
growth
factor-β
(TGF-β)
has
been
identified
one
of
key
factors
regulating
astrocyte
reactivity.
The
genetic
pharmacological
manipulation
TGF-β
signaling
pathway
in
animal
models
central
nervous
system
(CNS)
alters
pathological
functional
outcomes.
This
review
aims
provide
recent
understanding
regarding
injury,
aging,
neurodegeneration.
Further,
it
explores
how
modulates
function
context
CNS
injury.
Cells,
Journal Year:
2022,
Volume and Issue:
11(7), P. 1139 - 1139
Published: March 28, 2022
Several
neurodegenerative
disorders
involve
impaired
neurotransmission,
and
glutamatergic
neurotransmission
sets
a
prototypical
example.
Glutamate
is
predominant
excitatory
neurotransmitter
where
the
astrocytes
play
pivotal
role
in
maintaining
extracellular
levels
through
release
uptake
mechanisms.
Astrocytes
modulate
calcium-mediated
excitability
several
neurotransmitters
neuromodulators,
including
glutamate,
significantly
neurotransmission.
Accumulating
evidence
supports
concept
of
excitotoxicity
caused
by
astrocytic
pathological
conditions.
Thus,
current
review
highlights
different
vesicular
non-vesicular
mechanisms
glutamate
their
implication
diseases.
As
presynaptic
neurons,
also
primarily
meditated
exocytosis.
V-ATPase
crucial
acidification
maintenance
gradient
that
facilitates
storage
glutamate.
Along
with
these,
other
components,
such
as
cystine/glutamate
antiporter,
hemichannels,
BEST-1,
TREK-1,
purinergic
receptors
so
forth,
contribute
to
under
physiological
Events
hampered
could
promote
inflamed
trigger
repetitive
This
be
favorable
towards
development
worsening
Therefore,
across
diseases,
we
relations
between
defective
signaling
events
homeostasis.
The
optimum
regulation
transmission
pave
way
for
management
these
diseases
add
therapeutic
value.
Frontiers in Cellular Neuroscience,
Journal Year:
2023,
Volume and Issue:
17
Published: April 20, 2023
Reactive
astrogliosis
is
a
reaction
of
astrocytes
to
disturbed
homeostasis
in
the
central
nervous
system
(CNS),
accompanied
by
changes
astrocyte
numbers,
morphology,
and
function.
are
important
onset
progression
many
neuropathologies,
such
as
neurotrauma,
stroke,
neurodegenerative
diseases.
Single-cell
transcriptomics
has
revealed
remarkable
heterogeneity
reactive
astrocytes,
indicating
their
multifaceted
functions
whole
spectrum
with
temporal
spatial
resolution,
both
brain
spinal
cord.
Interestingly,
transcriptomic
signatures
partially
overlap
between
neurological
diseases,
suggesting
shared
unique
gene
expression
patterns
response
individual
neuropathologies.
In
era
single-cell
transcriptomics,
number
new
datasets
steeply
increases,
they
often
benefit
from
comparisons
integration
previously
published
work.
Here,
we
provide
an
overview
populations
defined
or
single-nucleus
across
multiple
attempting
facilitate
search
for
relevant
reference
points
improve
interpretability
containing
cells
astrocytes.
International Journal of Molecular Sciences,
Journal Year:
2023,
Volume and Issue:
24(24), P. 17146 - 17146
Published: Dec. 5, 2023
Neurological
disorders
have
been
linked
to
a
defective
blood–brain
barrier
(BBB),
with
dysfunctions
triggered
by
stage-specific
disease
mechanisms,
some
of
these
being
generated
through
interactions
in
the
neurovascular
unit
(NVU).
Advanced
knowledge
molecular
and
signaling
mechanisms
NVU
emergence
improved
experimental
models
allow
BBB
permeability
prediction
development
new
brain-targeted
therapies.
As
constituents,
astrocytes
are
most
numerous
glial
cells,
characterized
heterogeneity
that
occurs
as
result
developmental
context-based
gene
expression
profiles
differential
non-coding
ribonucleic
acids
(RNAs).
Due
their
dynamic
responses
different
signals,
may
beneficial
or
detrimental
role
BBB’s
function,
deep
effects
on
pathophysiology
(and
progression
of)
central
nervous
system
diseases.
The
implication
astrocytic-derived
extracellular
vesicles
pathological
due
ability
pass
BBB,
must
also
be
considered.
astrocytes’
interaction
endothelial
cells
at
level
considered
promising
therapeutic
targets
neurological
conditions.
Nevertheless,
personalized
well-founded
approach
addressed,
temporal
spatial
reactive
astrogliosis
states
during
disease.
International Journal of Molecular Sciences,
Journal Year:
2023,
Volume and Issue:
24(12), P. 9903 - 9903
Published: June 8, 2023
Neuroinflammation
is
one
of
the
postulated
mechanisms
for
Pb
neurotoxicity.
However,
exact
molecular
responsible
its
pro-inflammatory
effect
are
not
fully
elucidated.
In
this
study,
we
examined
role
glial
cells
in
neuroinflammation
induced
by
exposure.
We
investigated
how
microglia,
a
type
cell,
responded
to
changes
caused
perinatal
exposure
measuring
expression
Iba1
at
mRNA
and
protein
levels.
To
assess
state
analyzed
levels
specific
markers
associated
with
cytotoxic
M1
phenotype
(Il1b,
Il6,
Tnfa)
cytoprotective
M2
(Arg1,
Chi3l1,
Mrc1,
Fcgr1a,
Sphk1,
Tgfb1).
Additionally,
measured
concentration
cytokines
(IL-1β,
IL-6,
TNF-α).
reactivity
functionality
status
astrocytes,
GFAP
(mRNA
concentration)
as
well
glutamine
synthase
(GS)
level
activity.
Using
an
electron
microscope,
assessed
ultrastructural
abnormalities
brain
structures
(forebrain
cortex,
cerebellum,
hippocampus).
addition,
Cxcl1
Cxcl2,
their
receptor,
Cxcr2.
Our
data
showed
that
low
doses
affected
both
microglia
astrocyte
cells’
(their
mobilization,
activation,
function,
gene
profile)
brain-structure-specific
manner.
The
results
suggest
astrocytes
represent
potential
target
neurotoxicity,
thus
being
key
mediators
further
neuropathology
evoked
poisoning
during
development.
International Journal of Molecular Sciences,
Journal Year:
2023,
Volume and Issue:
24(2), P. 1599 - 1599
Published: Jan. 13, 2023
Both
astrocytic
and
microglial
functions
have
been
extensively
investigated
in
healthy
subjects
neurodegenerative
diseases.
For
astrocytes,
not
only
various
sub-types
were
identified
but
phagocytic
activity
was
also
clarified
recently
is
making
dramatic
progress.
In
this
review
paper,
we
mostly
focus
on
the
functional
role
of
astrocytes
extracellular
matrix
interactions
between
reactive
microglia
normal
states
diseases,
because
authors
feel
it
necessary
to
elucidate
mechanisms
among
activated
glial
cells
pathology
neurological
diseases
order
pave
way
for
drug
discovery.
Finally,
will
cyclic
phosphatidic
acid
(cPA),
a
naturally
occurring
phospholipid
mediator
that
induces
variety
biological
activities
brain
both
vivo
vitro.
We
propose
cPA
may
serve
as
novel
therapeutic
molecule
treatment
injury
neuroinflammation.
Advanced Science,
Journal Year:
2024,
Volume and Issue:
11(14)
Published: Feb. 2, 2024
Abstract
The
emergence
of
acute
ischemic
stroke
(AIS)
induced
cardiovascular
dysfunctions
as
a
bidirectional
interaction
has
gained
paramount
importance
in
understanding
the
intricate
relationship
between
brain
and
heart.
Post
AIS,
ensuing
encompass
spectrum
complications,
including
heart
attack,
congestive
failure,
systolic
or
diastolic
dysfunction,
arrhythmias,
electrocardiographic
anomalies,
hemodynamic
instability,
cardiac
arrest,
among
others,
all
which
are
correlated
with
adverse
outcomes
mortality.
Mounting
evidence
underscores
intimate
crosstalk
brain,
facilitated
by
physiological
neurohumoral
complex
networks.
primary
pathophysiological
mechanisms
contributing
to
these
severe
complications
involve
hypothalamic‐pituitary‐adrenal
(HPA)
axis,
sympathetic
parasympathetic
hyperactivity,
immune
inflammatory
responses,
gut
dysbiosis,
collectively
shaping
stroke‐related
brain–heart
axis.
Ongoing
research
endeavors
concentrated
on
devising
strategies
prevent
AIS‐induced
dysfunctions.
Notably,
labetalol,
nicardipine,
nitroprusside
recommended
for
hypertension
control,
while
β‐blockers
employed
avert
chronic
remodeling
address
arrhythmias.
However,
despite
therapeutic
interventions,
targets
remain
elusive,
necessitating
further
investigations
into
this
challenge.
This
review
aims
delineate
state‐of‐the‐art
AIS
through
preclinical
clinical
research,
unraveling
their
interplay
within
offering
pragmatic
suggestions
managing
Nanomaterials,
Journal Year:
2024,
Volume and Issue:
14(2), P. 160 - 160
Published: Jan. 11, 2024
Strokes
rank
as
the
second
most
common
cause
of
mortality
and
disability
in
human
population
across
world.
Currently,
available
methods
treating
or
preventing
strokes
have
significant
limitations,
primarily
need
to
use
high
doses
drugs
due
presence
blood-brain
barrier.
In
last
decade,
increasing
attention
has
been
paid
capabilities
nanotechnology.
However,
vast
majority
research
this
area
is
focused
on
mechanisms
anticancer
antiviral
effects
nanoparticles.
our
opinion,
not
enough
neuroprotective
nanomaterials.
review,
we
attempted
summarize
key
molecular
brain
cell
damage
during
ischemia.
We
discussed
current
literature
regarding
various
nanomaterials
for
treatment
strokes.
examined
features
all
known
nanomaterials,
possibility
which
are
currently
being
studied
regard,
positive
negative
properties
identified.
Particular
review
was
nanoselenium
since
selenium
a
vital
microelement
part
very
important
little-studied
proteins,
e.g.,
selenoproteins
selenium-containing
proteins.
An
analysis
modern
studies
cytoprotective
made
it
possible
establish
acute
chronic
protective
aimed
combine
information
action
nanoparticles
neurodegenerative
processes,
especially
cerebral